These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31319558)

  • 41. The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis.
    Mojtabanezhad Shariatpanahi A; Yassi M; Nouraie M; Sahebkar A; Varshoee Tabrizi F; Kerachian MA
    PLoS One; 2018; 13(7):e0200735. PubMed ID: 30024936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer.
    Sahnane N; Magnoli F; Bernasconi B; Tibiletti MG; Romualdi C; Pedroni M; Ponz de Leon M; Magnani G; Reggiani-Bonetti L; Bertario L; Signoroni S; Capella C; Sessa F; Furlan D;
    Clin Epigenetics; 2015; 7():131. PubMed ID: 26697123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer.
    Galamb O; Kalmár A; Péterfia B; Csabai I; Bodor A; Ribli D; Krenács T; Patai ÁV; Wichmann B; Barták BK; Tóth K; Valcz G; Spisák S; Tulassay Z; Molnár B
    Epigenetics; 2016 Aug; 11(8):588-602. PubMed ID: 27245242
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis.
    Bhangu JS; Beer A; Mittlböck M; Tamandl D; Pulverer W; Schönthaler S; Taghizadeh H; Stremitzer S; Kaczirek K; Gruenberger T; Gnant M; Bergmann M; Mannhalter C; Weinhäusel A; Oehler R; Bachleitner-Hofmann T
    Ann Surg; 2018 Nov; 268(5):894-902. PubMed ID: 30080722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer.
    Liu S; Chen X; Chen R; Wang J; Zhu G; Jiang J; Wang H; Duan S; Huang J
    Oncotarget; 2017 May; 8(22):36354-36367. PubMed ID: 28422739
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Study of Promoter Methylation Patterns of HOXA2, HOXA5, and HOXA6 and Its Clinicopathological Characteristics in Colorectal Cancer.
    Li D; Bai Y; Feng Z; Li W; Yang C; Guo Y; Lin C; Zhang Y; He Q; Hu G; Li X
    Front Oncol; 2019; 9():394. PubMed ID: 31165042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions.
    Huang ZH; Li LH; Yang F; Wang JF
    World J Gastroenterol; 2007 Feb; 13(6):950-4. PubMed ID: 17352030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
    Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic Values of EPDR1 Hypermethylation and Its Inhibitory Function on Tumor Invasion in Colorectal Cancer.
    Chu CH; Chang SC; Wang HH; Yang SH; Lai KC; Lee TC
    Cancers (Basel); 2018 Oct; 10(10):. PubMed ID: 30360391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of body weight on altered expression of nuclear receptors and cyclooxygenase-2 in human colorectal cancers.
    Delage B; Rullier A; Capdepont M; Rullier E; Cassand P
    Nutr J; 2007 Sep; 6():20. PubMed ID: 17767717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic and predictive significance of long interspersed nucleotide element-1 methylation in advanced-stage colorectal cancer.
    Kaneko M; Kotake M; Bando H; Yamada T; Takemura H; Minamoto T
    BMC Cancer; 2016 Dec; 16(1):945. PubMed ID: 27955637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Secreted Frizzled Related Protein 2 Modulates Epithelial-Mesenchymal Transition and Stemness via Wnt/β-Catenin Signaling in Choriocarcinoma.
    Zeng X; Zhang Y; Xu H; Zhang T; Xue Y; An R
    Cell Physiol Biochem; 2018; 50(5):1815-1831. PubMed ID: 30396168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adolescent body mass index and erythrocyte sedimentation rate in relation to colorectal cancer risk.
    Kantor ED; Udumyan R; Signorello LB; Giovannucci EL; Montgomery S; Fall K
    Gut; 2016 Aug; 65(8):1289-95. PubMed ID: 25986947
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
    Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S
    Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessing the potential value of long interspersed element-1 hypomethylation in colorectal cancer: evidence from retrospective studies.
    Tang JT; Wang ZH; Fang JY
    Onco Targets Ther; 2015; 8():3265-76. PubMed ID: 26604793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methylation-mediated loss of SFRP2 enhances invasiveness of non-small cell lung cancer cells.
    Zhang X; Rong X; Chen Y; Su L
    Hum Exp Toxicol; 2018 Feb; 37(2):155-162. PubMed ID: 29320940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.
    Ying J; Li H; Yu J; Ng KM; Poon FF; Wong SC; Chan AT; Sung JJ; Tao Q
    Clin Cancer Res; 2008 Jan; 14(1):55-61. PubMed ID: 18172252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Excess body weight and colorectal cancer survival: the multiethnic cohort.
    Maskarinec G; Harmon BE; Little MA; Ollberding NJ; Kolonel LN; Henderson BE; Le Marchand L; Wilkens LR
    Cancer Causes Control; 2015 Dec; 26(12):1709-18. PubMed ID: 26358830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of Obesity With Risk of Early-Onset Colorectal Cancer Among Women.
    Liu PH; Wu K; Ng K; Zauber AG; Nguyen LH; Song M; He X; Fuchs CS; Ogino S; Willett WC; Chan AT; Giovannucci EL; Cao Y
    JAMA Oncol; 2019 Jan; 5(1):37-44. PubMed ID: 30326010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Body mass index (BMI) trajectories and risk of colorectal cancer in the PLCO cohort.
    Zheng R; Du M; Zhang B; Xin J; Chu H; Ni M; Zhang Z; Gu D; Wang M
    Br J Cancer; 2018 Jul; 119(1):130-132. PubMed ID: 29872147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.